Real-time enrollment status for this generalized myasthenia gravis (gmg) clinical trial
Current Status
Recruiting
Checked: October 17, 2026 at 3:34 AM UTC
| NCT Number | NCT07215949 |
| Recruiting Status | Recruiting |
| Condition | Generalized Myasthenia Gravis (gMG) |
| Phase | PHASE3 |
| Target Enrollment | 15 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Miriam Freimer |
| Last Updated on CT.gov | August 28, 2026 (Aug 28, 2026) |
As of October 17, 2026: Clinical trial NCT07215949 is currently recruiting participants. This phase3 study for generalized myasthenia gravis (gmg) is actively seeking new participants at 3 locations across the United States. The study is sponsored by Miriam Freimer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07215949 is actively recruiting participants as of October 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07215949 was last updated Aug 28, 2026 (August 28, 2026). HelloStudys verifies this status automatically.